Title : Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.

Pub. Date : 2021

PMID : 34557417






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway. ros protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens